Interrelation between the concentrations of bone remodeling markers, osteoporosis and the risk of pathological bone fractures in patients with rheumatoid arthritis
https://doi.org/10.25789/YMJ.2019.68.10
Abstract
The article reports the study of possibility of predicting bone fractures by determining the concentration of bone remodeling markers in patients with rheumatoid arthritis (RA).
It was revealed that at RA, complicated by osteoporosis, as well as in the presence of pathological bone fractures in patients, an increase in C-telopeptide type I collagen, serum P1NP, urine calcium / creatinine, and a decrease in serum 25-OH vitamin D are observed.
About the Authors
Yu. R. AkhverdyanRussian Federation
Akhverdyan Yury R. - PhD in Medicine, Senior Researcher at the Laboratory of methods for the treatment and prevention of joint diseases
400138, Volgograd, 76 Zemlyachki St., phone (work): (8442) 789098
B. V. Zavodovsky
Russian Federation
Zavodovsky Boris V. - Doctor of Medical Sciences, Deputy Director for Scientific Issues
the head of laboratory of methods of treatment and prevention of joint diseases
address: 400138, Volgograd, 76 Zemlyachki St., tel. work: (8442) 78-90-93
Yu. V. Polyakova
Russian Federation
Polyakova Yulia V. - PhD in Medicine, Researcher
400138, Volgograd, 76 Zemlyachki St., tel.: (8442) 78-90-93
L. E. Seewordova
Russian Federation
Seewordova Larisa E. - PhD in Medicine, leading researcher at the laboratory of methods for the treatment and prevention of joint diseases
400138, Volgograd, 76 Zemlyachki St., tel. office: (8442) 78-90-93
E. V. Papichev
Russian Federation
Papichev Evgeny V. - Junior Researcher at the Laboratory for Methods of Treatment and Prevention of Joint Diseases
400138, Volgograd, 76 Zemlyachki St., tel. office: (8442) 78-90-93
References
1. Features of osteoporosis and risk factors for its development in female patients with rheumatoid arthritis in the age aspect / S.E. Myasoedova [et al]. // Modern problems of science and education. - 2016. - №2. - P. 103.
2. Osteoporosis in rheumatoid arthritis: risk factors for osteoporosis development / M.M. Podvorotova [et al.] // Scientific and practical rheumatology. - 2013. - №51. - P. 121.
3. Prevalence of rheumatoid arthritis in Russia (according to the epidemiological study) / S.E. Myasoedova [et al]. // Therapeutic archive. - 2010. - №5. - P. 9-14.
4. Bone mineral density in patients with rheumatoid arthritis / L. Macovei [et al.] // Rev Med Chir Soc Med Nat Iasi. – 2011. - №115. – Р. 723-730.
5. Competing mortality and fracture risk assessment / W.D. Leslie [et al.] // Osteoporos Int. - 2013. №24. – Р. 681–8.
6. Epidemiology and treatment of New-Onset and Established Rheumatoid Arthritis in an Insured US Population / M.M. Crane [et al.] // Arthritis Care Res (Hoboken). - 2015. - №67. – Р. 1646–55.
7. Manitoba Bone Density Program. Does osteoporosis therapy invalidate FRAX for fracture prediction? / W.D. Leslie [et al.] // J Bone Miner Res. – 2012. - №27. –Р. 1243–51.
8. Osteoporosis in rheumatoid arthritis / R.V. Murariu, L.A. Macovei, I.C. Brujbu // Rev Med Chir Soc Med Nat Iasi. – 2013. - №117. – Р. 394-403
9. Serum levels of osteoprotegerin and RANKL in patients with rheumatoid arthritis and their relation to bone mineral density and disease activity / S. Fadda [et al.] // Egypt Rheumatol. - 2015. – Vol. 37, №1. – Р. 1-6
10. The accuracy of osteoporotic fracture risk prediction tools: a systematic review and meta-analysis / А. Marques [et al.] // Ann Rheum Dis. – 2015. - №74. – Р. 1958–67.
Review
For citations:
Akhverdyan Yu.R., Zavodovsky B.V., Polyakova Yu.V., Seewordova L.E., Papichev E.V. Interrelation between the concentrations of bone remodeling markers, osteoporosis and the risk of pathological bone fractures in patients with rheumatoid arthritis. Yakut Medical Journal. 2019;(4):43-45. https://doi.org/10.25789/YMJ.2019.68.10